|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Relistor.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
Actonel.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
Vyvanse.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
Advair Diskus 250/50.(FDA actions in brief)(Drug overview)(Brief artic...
June 01, 2008
Orencia.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
Iloperidone: a novel atypical antipsychotic for the treatment of schiz...
June 01, 2008
Review of inhaled corticosteroid/long-acting [beta.sub.2]-agonist comb...
June 01, 2008
Glatiramer effective in delaying clinical MS: from the 60th Annual Mee...
June 01, 2008
Lacosamide decreases diabetic neuropathic pain.(Meeting Coverage)(Repo...
June 01, 2008
Glatiramer, interferon beta-1b comparable in early RRMS.(relapsing-rem...
June 01, 2008
Electronic medication management system available to improve medicatio...
June 01, 2008
Selected literature.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE...
June 01, 2008
Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S...
June 01, 2008
Bipolar disorder and psychosis.(Drug Watch: A HEADS-UP ON PHARMACEUTIC...
June 01, 2008
Surfaxin.(Approvable designation)(Brief article)
June 01, 2008
Cinryze.(Recommended for approval)(Brief article)
June 01, 2008
Loratadine/montelukast combination (Schering-Plough/Merck).(Nonapprova...
June 01, 2008
Extended-release niacin/laropiprant.(Nonapprovable designations)(Brief...
June 01, 2008
Icatibant.(Nonapprovable designations)(Brief article)
June 01, 2008
Fentora.(Not recommended for approval)(Brief article)
June 01, 2008
NPL-2008.(Fast-track designation)(Brief article)
June 01, 2008
Carfilzomib.(Orphan drug designations)(Brief article)
June 01, 2008
Resveratrol.(Orphan drug designations)(Brief article)
June 01, 2008
Aerosolized alpha-1 antitrypsin.(Orphan drug designations)(Brief artic...
June 01, 2008
Rhitol.(Orphan drug designations)(Brief article)
June 01, 2008
Cimzia: Certolizumab pegol.(New biologic)
June 01, 2008
Amitiza: Lubiprostone.(New indication)
June 01, 2008
First-time generic approvals.(FDA Drug Approvals)(Brief article)
June 01, 2008
Rotarix.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
Pantanase.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
Treximet.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
Aplenzin.(FDA actions in brief)(Drug overview)(Brief article)
June 01, 2008
|